asynchronous TELEmedicine for patients with Rheumatoid Arthritis

asynchronous TELEmedicine for patients with Rheumatoid Arthritis - TELERA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00024928

Enrollment

120

Registered

2021-04-09

Start date

2021-06-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnosis of RA according to ACR/EULAR-Classification Criteria 2010

Interventions

Group 1: In this multi-center pilot study, patients with rheumatoid arthritis (RA) will perform a clinical self-assessment including joint examination and capillary self-sampling at two routine appoin

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: sufficient German language skills Use of a smartphone written declaration of consent

Exclusion criteria

Exclusion criteria: Insufficient language skills Not in possession of a smartphone

Design outcomes

Primary

Measure	Time frame
Consistency of a) medical telemedical therapeutic decisions, b) conventional therapeutic decisions based on the physical visit, and c) patient decisions	—

Secondary

Measure	Time frame
• Correspondence of the electronically recorded and paper-based Clinical Disease Activity Index (CDAI) for rheumatoid arthritis by the patient • Correspondence between the joint status recorded by the patient and the rheumatologist • Qualitative feedback on patient acceptance, app compliance, changes in self-management and self-efficacy • Change in patient self-management confidence (Patient Activation Measure, PAM) • Acceptance of the ABATON software among doctors (system usability scale and the net promoter score) • Acceptance of the ABATON software among patients (system usability scale and the net promoter score) • Acceptance of self-sampling among patients (net promoter score) • Change in the accuracy of the rheumatologist's assessment of clinical activity (VAS 0-10) • Change in the accuracy of the patient's assessment of clinical activity (VAS 0-10) • Willingness to substitute routine appointments with telemedicine appointments among rheumatologists (Net Promoter Score) • Willingness to substitute routine appointments with telemedicine appointments among patients (net promoter score)	—

Measure

Time frame

• Correspondence of the electronically recorded and paper-based Clinical Disease Activity Index (CDAI) for rheumatoid arthritis by the patient • Correspondence between the joint status recorded by the patient and the rheumatologist • Qualitative feedback on patient acceptance, app compliance, changes in self-management and self-efficacy • Change in patient self-management confidence (Patient Activation Measure, PAM) • Acceptance of the ABATON software among doctors (system usability scale and the net promoter score) • Acceptance of the ABATON software among patients (system usability scale and the net promoter score) • Acceptance of self-sampling among patients (net promoter score) • Change in the accuracy of the rheumatologist's assessment of clinical activity (VAS 0-10) • Change in the accuracy of the patient's assessment of clinical activity (VAS 0-10) • Willingness to substitute routine appointments with telemedicine appointments among rheumatologists (Net Promoter Score) • Willingness to substitute routine appointments with telemedicine appointments among patients (net promoter score)

—

Countries

Germany

Contacts

Public ContactAnn-Christin;Johannes Pecher;Knitza

Universitätsklinikum Tübingen, Innere Medizin II Rheumatologische Ambulanz;Medizinische Klinik 3, Universitätsklinikum Erlangen

ann-christin.pecher@med.uni-tuebingen.de;johannes.knitza@uk-erlangen.de07071/29-68845;+4991318534742

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 13, 2026